Skip to main content

Advertisement

Table 1 Patient and Tumour characteristics

From: Clinical relevance of "withdrawal therapy" as a form of hormonal manipulation for breast cancer

Median age = 84.3 (53.7-92.5) years
Histopathology Invasive adenocarcinoma = 12 Mixed Tubular + Cribriform = 1 Not available = 4
Median ER (estrogen receptor) H score 185 (IQR, 97.5-222)
Median Disease Free Interval (DFI) 84 (IQR, 19-180) months
Metastatic Sites Bone = 6 Pleura/Effusion = 4 Lung = 2 Liver = 5 Supraclavicular/mediastinal Lymph node = 2
Median lines of therapy prior to withdrawal 5 (range 1-9)
Median TTP (time to progression) on endocrine agent prior to withdrawal 6 (IQR, 3-17) months